| |
|
|
|
Matinas Biopharma Hl  
|
|
1.64 -0.03 (-0.02%) |
01-15 16:00 |
|
Open: |
1.7 |
Pre close: |
1.67 |
Target:
|
2.59
|
|
High: |
1.72 |
Low: |
1.6 |
Resistance:
|
2.22
2.59
|
|
Volume: |
3,542,202 |
Market Cap: |
327M |
Support:
|
1.37
0.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.63
 |
MACD |
MACD(12,26):
|
0.17  |
|
MA(20): |
1.35 |
Signal(12,26,9): |
0.15 |
|
MA(100): |
0.95 |
Stochastic Oscillator |
%K(14,3):
|
57.60 |
|
MA(250): |
0.91 |
%D(3): |
56.30 |
|
Average Volume(K) |
3-Month: |
437959
|
52-Week |
High:
|
2.22 |
|
10-Days: |
910056 |
Low: |
0.49 |
|
RSI |
RSI(14):
|
64.13 |
Change(%): |
5.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.121 |
Return on Equity (ttm) |
-36.4 |
Shares Out. (M) |
198.95 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-22.0 |
Shares Float (M) |
162.10 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.55 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.78 |
|
Forward EPS |
-0.150 |
Gross Profit (p.s.) |
-0.056 |
Shares Short (K) |
16300 |
|
Book Value (p.s.) |
0.350 |
EBITDA (p.s.) |
-0.111 |
P/E |
-13.55 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.69 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.81 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-11.28 |
P/CF |
-19.41 |
|
|
|
|
|
|
